Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2665-9786
  • E-ISSN: 2665-9794

Abstract

Background

Colon delivery systems are designed for the oral delivery of active compounds in the large intestine. Food-grade copolymers Eudraguard® Biotic (EUGB) and control (EUGC) have been investigated to develop colloidal systems loading natural active ingredients.

Methods

In this study, we evaluated the degradation process of these matrices in simulated gastric, intestinal and colonic conditions. Microparticles made of EUGB and EUGC, alone or in combination, were loaded with the model compound resveratrol (RSV). A parallel study was performed on RSV release and SEM analysis of microparticles kept at different pH values.

Results

All systems ensured a limited gastric release of RSV (below 20%), presenting only small pores on the surface of microparticles treated with simulated gastric fluid. EUGB microparticles showed the maximum release in simulated colon fluid (SCF), showing a complete dissolution of the microparticle matrix. The EUGC-based system allowed a prolonged release of RSV over time, and in SCF, it showed only partial degradation. Using mixed EUGB/EUGC matrices, a prolonged RSV release was observed along the intestinal tract.

Conclusion

Overall, EUGB and EUGC copolymers were able to modulate and localize the release of entrapped cargo in the small intestine and colon. They could have interesting applications in treating bowel diseases synergistically with other therapeutic strategies.

Loading

Article metrics loading...

/content/journals/cnt/10.2174/2665978604666230201144421
2023-03-30
2025-09-03
Loading full text...

Full text loading...

References

  1. BadhanaS. GarudN. GarudA. Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan microspheres for the treatment of ulcerative colitis.Int. Curr. Pharm. J.201323424810.3329/icpj.v2i3.13577
    [Google Scholar]
  2. BiondiM. IndolfiL. UngaroF. QuagliaF. La RotondaM.I. NettiP.A. Bioactivated collagen-based scaffolds embedding protein-releasing biodegradable microspheres: Tuning of protein release kinetics.J. Mater. Sci. Mater. Med.200920102117212810.1007/s10856‑009‑3766‑519449203
    [Google Scholar]
  3. BottC. RudolphM.W. SchneiderA.R.J. SchirrmacherS. SkalskyB. PetereitH.U. LangguthP. DressmanJ.B. SteinJ. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system.Aliment. Pharmacol. Ther.200420334735310.1111/j.1365‑2036.2004.02033.x15274672
    [Google Scholar]
  4. CuiM. ZhangM. LiuK. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review.Carbohydr. Polym.202127211853010.1016/j.carbpol.2021.11853034420762
    [Google Scholar]
  5. CurcioC. BonaccorsoA. MusumeciT. PignatelloR. Oral controlled delivery of natural compounds using food-grade polymer microparticles.Curr. Nutra.20212214515310.2174/2665978601999201126212614
    [Google Scholar]
  6. CurcioC. GrecoA.S. RizzoS. SaittaL. MusumeciT. RuoziB. PignatelloR. Development, optimization and characterization of Eudraguard®-based microparticles for colon delivery.Pharmaceuticals202013613110.3390/ph1306013132599861
    [Google Scholar]
  7. de Arce VelasquezA. FerreiraL.M. StangarlinM.F.L. da SilvaC.B. RolimC.M.B. CruzL. Novel Pullulan-Eudragit® S100 blend microparticles for oral delivery of risedronate: Formulation, in vitro evaluation and tableting of blend microparticles.Mater. Sci. Eng. C201438121221710.1016/j.msec.2014.02.00324656371
    [Google Scholar]
  8. World Health OrganizationDissolution test for solid dosage forms. Draft proposal for revision in The International Pharmacopoeia. June2022Available from: https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/qas20-837-dissolution-test-for-solid-oral-dosage-forms.pdf?sfvrsn=f712c6df_2
  9. DvořáckováK. KalėdaitėR. GajdziokJ. RabiškováM. BajerováM. MuselíkJ. LažauskasR. PečiūraR. The development of Eudragit® NM-based controlled-release matrix tablets.Medicina201248419220210.3390/medicina48040028
    [Google Scholar]
  10. DubeyR. DubeyR. OmreyP. VyasS.P. JainS.K. Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis.J. Drug Target.201018858960110.3109/1061186090357293320088681
    [Google Scholar]
  11. EiseleJ. HaynesG. KreuzerK. HallC. Toxicological assessment of anionic methacrylate copolymer: I. Characterization, bioavailability and genotoxicity.Regul. Toxicol. Pharmacol.201682394710.1016/j.yrtph.2016.11.00927825834
    [Google Scholar]
  12. Evonik datasheets.Available from: https://healthcare.evonik.com/en/products/nutritional-coatings/ (Accessed on: May 20, 2022).
  13. GhattamaneniN.K.R. PanchalS.K. BrownL. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease.Pharmacol. Res.20181329910710.1016/j.phrs.2018.04.01529680446
    [Google Scholar]
  14. KleinS. The use of biorelevant dissolution media to forecast the in vivo performance of a drug.AAPS J.201012339740610.1208/s12248‑010‑9203‑320458565
    [Google Scholar]
  15. LaracuenteM.L. YuM.H. McHughK.J. Zero-order drug delivery: State of the art and future prospects.J. Control. Release202032783485610.1016/j.jconrel.2020.09.02032931897
    [Google Scholar]
  16. LautenschlägerC. SchmidtC. FischerD. StallmachA. Drug delivery strategies in the therapy of inflammatory bowel disease.Adv. Drug Deliv. Rev.201471587610.1016/j.addr.2013.10.00124157534
    [Google Scholar]
  17. LeeS.H. BajracharyaR. MinJ.Y. HanJ.W. ParkB.J. HanH.K. Strategic approaches for colon targeted drug delivery: An overview of recent advancements.Pharmaceutics20201216810.3390/pharmaceutics1201006831952340
    [Google Scholar]
  18. Mathematical models of drug release.Strategies to Modify the Drug Release from Pharmaceutical Systems.AmsterdamElsevier20156386
    [Google Scholar]
  19. MengT. XiaoD. MuhammedA. DengJ. ChenL. HeJ. Anti-inflammatory action and mechanisms of resveratrol.Molecules202126122910.3390/molecules2601022933466247
    [Google Scholar]
  20. MijanM.A. LimB.O. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.World J. Gastroenterol.201824252673268510.3748/wjg.v24.i25.267329991873
    [Google Scholar]
  21. MircioiuC. VoicuV. AnutaV. TudoseA. CeliaC. PaolinoD. FrestaM. SanduloviciR. MircioiuI. Mathematical modeling of release kinetics from supramolecular drug delivery systems.Pharmaceutics201911314010.3390/pharmaceutics1103014030901930
    [Google Scholar]
  22. MusumeciT. BonaccorsoA. CarboneC. ImpallomeniG. BallistreriA. DuskeyJ.T. PuglisiG. PignatelloR. Development and biocompatibility assessments of poly(3-hydroxybutyrate-co-ε-caprolactone) microparticles for diclofenac sodium delivery.J. Drug Deliv. Sci. Technol.20206010208110.1016/j.jddst.2020.102081
    [Google Scholar]
  23. MusumeciT. CupriS. BonaccorsoA. ImpallomeniG. BallistreriA. PuglisiG. PignatelloR. Technology assessment of new biode-gradable poly(R‐3‐hydroxybutyrate‐co‐1,4‐butylene adipate) copolymers for drug delivery.J. Appl. Polym. Sci.2019136124723310.1002/app.47233
    [Google Scholar]
  24. NunesS. DanesiF. Del RioD. SilvaP. Resveratrol and inflammatory bowel disease: the evidence so far.Nutr. Res. Rev.2018311859710.1017/S095442241700021X29191255
    [Google Scholar]
  25. PignatelloR. ConsoliP. PuglisiG. In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles.J. Microencapsul.200017337338310.1080/02652040028833710819424
    [Google Scholar]
  26. PignatelloR. PecoraT.M.G. CutuliG.G. CatalfoA. De GuidiG. RuoziB. TosiG. CiancioloS. MusumeciT. Antioxidant activity and photostability assessment of trans-resveratrol acrylate microspheres.Pharm. Dev. Technol.201924222223410.1080/10837450.2018.145569729565215
    [Google Scholar]
  27. Scientific opinion on the safety of anionic methacrylate copolymer for the proposed uses as a food additive. (2010).EFSA J.165687.
    [Google Scholar]
  28. ShinD.W. LimB.O. Nutritional interventions using functional foods and nutraceuticals to improve inflammatory bowel disease.J. Med. Food202023111136114510.1089/jmf.2020.471233047999
    [Google Scholar]
  29. SpogliR. BastianiniM. RagoneseF. IannittiR. MonarcaL. BastioliF. NakashidzeI. BrecchiaG. MenchettiL. CodiniM. ArcuriC. MancinelliL. FiorettiB. Solid dispersion of resveratrol supported on magnesium dihydroxide (Resv@MDH) microparticles improves oral bioavailability.Nutrients20181012192510.3390/nu1012192530563110
    [Google Scholar]
  30. WangQ.S. WangG.F. ZhouJ. GaoL.N. CuiY.L. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.Int. J. Pharm.20165151-217618510.1016/j.ijpharm.2016.10.00227713029
    [Google Scholar]
  31. XunW. FuQ. ShiL. CaoT. JiangH. MaZ. Resveratrol protects intestinal integrity, alleviates intestinal inflammation and oxidative stress by modulating AhR/Nrf2 pathways in weaned piglets challenged with diquat.Int. Immunopharmacol.20219910798910.1016/j.intimp.2021.10798934303281
    [Google Scholar]
  32. ZhangF. Melt-extruded Eudragit® FS-based granules for colonic drug delivery.AAPS Pharm. Sci. Tech.2016171566710.1208/s12249‑015‑0357‑226162974
    [Google Scholar]
/content/journals/cnt/10.2174/2665978604666230201144421
Loading
/content/journals/cnt/10.2174/2665978604666230201144421
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test